Patrick M. Mutua1*, Joshua M. Mutiso2, Jemimah A. Simabuni2, Michael M. Gicheru2
An open access, peer-reviewed vaccinology journal publishing research on vaccine development, immunization and vaccine safety.
The Journal of Vaccinology is a peer-reviewed, open access journal covering vaccine research, immunoprophylaxis and immunotherapeutics, from antigen discovery to population-level immunization. It provides a shared forum for immunologists, virologists, molecular biologists, epidemiologists, clinicians and biotechnology researchers.
Its scope includes vaccine design and development, from recombinant, nanoparticle, mRNA, DNA and viral-vector platforms to adjuvants and epitope mapping; innate and adaptive immune responses to vaccination and long-term immune memory; and therapeutic vaccines for cancer, autoimmune and neurodegenerative disease. Clinical and translational work is central, including phase I to IV trials, safety assessment, vaccine performance in older, immunocompromised and newborn populations, response biomarkers and post-marketing effectiveness studies.
The journal also covers emerging infections and pandemic preparedness, delivery systems and cold-chain-independent formulations, manufacturing and regulation, and public health questions such as vaccine hesitancy, access in low-resource settings, cost-effectiveness and ethics.
Original research, systematic reviews, meta-analyses and expert perspectives are considered. All articles are open access under CC BY 4.0 and receive a DOI.
Advancing Immunization Science for Global Health
The Journal of Vaccinology is a premier open-access, peer-reviewed platform dedicated to cutting-edge research in vaccine science, immunotherapy, and immunoprophylaxis. The journal covers a broad spectrum of topics, including the development of prophylactic and therapeutic vaccines, novel immunization strategies, and emerging immunotherapeutics aimed at combating infectious diseases, cancer, and autoimmune disorders.
With a strong emphasis on laboratory research, clinical trials, and translational studies, Journal of Vaccinology fosters interdisciplinary collaboration among scientists, clinicians, and industry leaders. By addressing critical challenges in vaccine development, immunological mechanisms, and real-world implementation, we aim to bridge the gap between fundamental research and clinical application.
Our mission is to drive scientific dialogue and innovation in vaccinology while engaging the pharmaceutical, biotechnology, and public health communities to accelerate progress in global immunization and disease prevention.
Join us in shaping the future of vaccine science and immunotherapy!
Patrick M. Mutua1*, Joshua M. Mutiso2, Jemimah A. Simabuni2, Michael M. Gicheru2
We offer editing services to help you prepare a submission-ready manuscript.
Learn more
The journal works hard to maximize the impact of published research.
Learn more
Journal of Vaccinology offers a professional quality Reprint Service that enables users to have reprints delivered to their door at an affordable value.
Learn more
Yes. Every manuscript is reviewed by independent subject experts before the editors make a decision.
Yes. All articles are free to read and download, and are published under a Creative Commons Attribution (CC BY 4.0) licence.
Vaccine design and development, immune responses to vaccination, therapeutic vaccines, clinical trials, pandemic preparedness, vaccine delivery and immunization policy.
Original research, systematic reviews, meta-analyses and expert perspectives.
The APC is charged only after a manuscript is accepted for publication. There is no fee to submit.
Accepted articles are published online as soon as they are ready, without waiting for the full issue to be completed.
Yes. Every published article is assigned a DOI so it can be cited and found permanently.
Use the Sign in link at the top of this page to open the author portal, then submit your manuscript online.